Compare Panacea Biotech with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs DISHMAN PHARMA - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH DISHMAN PHARMA PANACEA BIOTECH/
DISHMAN PHARMA
 
P/E (TTM) x 11.5 25.1 46.0% View Chart
P/BV x 4.5 3.3 134.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 PANACEA BIOTECH   DISHMAN PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
DISHMAN PHARMA
Mar-16
PANACEA BIOTECH/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs354374 94.4%   
Low Rs138129 107.2%   
Sales per share (Unadj.) Rs74.6197.8 37.7%  
Earnings per share (Unadj.) Rs6.721.2 31.5%  
Cash flow per share (Unadj.) Rs15.534.7 44.6%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs57.2179.9 31.8%  
Shares outstanding (eoy) m61.2580.69 75.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.31.3 259.2%   
Avg P/E ratio x36.811.9 310.2%  
P/CF ratio (eoy) x15.97.2 219.0%  
Price / Book Value ratio x4.31.4 307.3%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m15,06120,306 74.2%   
No. of employees `0002.30.8 279.1%   
Total wages/salary Rs m1,4715,355 27.5%   
Avg. sales/employee Rs Th1,973.619,252.7 10.3%   
Avg. wages/employee Rs Th635.66,459.5 9.8%   
Avg. net profit/employee Rs Th176.82,064.1 8.6%   
INCOME DATA
Net Sales Rs m4,56715,961 28.6%  
Other income Rs m45265 16.9%   
Total revenues Rs m4,61216,226 28.4%   
Gross profit Rs m2,0304,103 49.5%  
Depreciation Rs m5401,091 49.5%   
Interest Rs m1,048944 111.0%   
Profit before tax Rs m4862,334 20.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77624 12.4%   
Profit after tax Rs m4091,711 23.9%  
Gross profit margin %44.425.7 172.9%  
Effective tax rate %15.926.7 59.3%   
Net profit margin %9.010.7 83.6%  
BALANCE SHEET DATA
Current assets Rs m2,41511,018 21.9%   
Current liabilities Rs m9,0779,517 95.4%   
Net working cap to sales %-145.99.4 -1,551.4%  
Current ratio x0.31.2 23.0%  
Inventory Days Days65110 58.9%  
Debtors Days Days7135 203.6%  
Net fixed assets Rs m8,33316,304 51.1%   
Share capital Rs m61161 38.0%   
"Free" reserves Rs m3,44312,907 26.7%   
Net worth Rs m3,50414,516 24.1%   
Long term debt Rs m4614,189 11.0%   
Total assets Rs m13,75529,805 46.2%  
Interest coverage x1.53.5 42.2%   
Debt to equity ratio x0.10.3 45.6%  
Sales to assets ratio x0.30.5 62.0%   
Return on assets %10.68.9 118.9%  
Return on equity %11.711.8 99.0%  
Return on capital %38.717.5 220.8%  
Exports to sales %20.924.8 84.3%   
Imports to sales %8.13.7 218.0%   
Exports (fob) Rs m9543,956 24.1%   
Imports (cif) Rs m372596 62.4%   
Fx inflow Rs m1,2034,952 24.3%   
Fx outflow Rs m467697 67.0%   
Net fx Rs m7364,255 17.3%   
CASH FLOW
From Operations Rs m1,0492,786 37.6%  
From Investments Rs m-54-1,529 3.5%  
From Financial Activity Rs m-1,011-941 107.5%  
Net Cashflow Rs m-20316 -6.2%  

Share Holding

Indian Promoters % 74.5 61.4 121.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 3.7 16.2%  
FIIs % 1.3 12.7 10.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 22.1 106.8%  
Shareholders   10,259 46,261 22.2%  
Pledged promoter(s) holding % 35.1 35.8 98.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Apr 16, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS